Show simple item record

dc.contributor.authorNordal, Ellen Berit
dc.contributor.authorRypdal, Veronika Gjertsen
dc.contributor.authorArnstad, Ellen Dalen
dc.contributor.authorAalto, Kristiina
dc.contributor.authorBerntson, Lillemor
dc.contributor.authorEkelund, Maria
dc.contributor.authorFasth, Anders
dc.contributor.authorGlerup, Mia
dc.contributor.authorHerlin, Troels
dc.contributor.authorNielsen, Susan
dc.contributor.authorPeltoniemi, Suvi
dc.contributor.authorZak, Marek
dc.contributor.authorSongstad, Nils Thomas
dc.contributor.authorRygg, Marite
dc.date.accessioned2019-12-10T08:41:36Z
dc.date.available2019-12-10T08:41:36Z
dc.date.created2019-09-06T11:26:32Z
dc.date.issued2019
dc.identifier.citationPediatric Rheumatology. 2019, 17:44 1-10.nb_NO
dc.identifier.issn1546-0096
dc.identifier.urihttp://hdl.handle.net/11250/2632396
dc.description.abstractBackground The aim of the study was to describe school attendance and participation in physical education in school among children with juvenile idiopathic arthritis (JIA). Methods Consecutive cases of JIA from defined geographical areas of Finland, Sweden and Norway with disease onset in 1997 to 2000 were followed for 8 years in a multi-center cohort study, aimed to be as close to population-based as possible. Clinical characteristics and information on school attendance and participation in physical education (PE) were registered. Results Participation in school and in PE was lowest initially and increased during the disease course. Eight years after disease onset 228/274 (83.2%) of the children reported no school absence due to JIA, while 16.8% reported absence during the last 2 months due to JIA. Full participation in PE was reported by 194/242 (80.2%), partly by 16.9%, and none by 2.9%. Lowest participation in PE was found among children with ERA and the undifferentiated categories. Absence in school and PE was associated with higher disease activity measures at the 8-year visit. School absence > 1 day at baseline predicted use of disease-modifying anti-rheumatic drugs, including biologics (DMARDs) (OR 1.2 (1.1–1.5)), and non-remission off medication (OR 1.4 (1.1–1.7) 8 years after disease onset. Conclusion School absence at baseline predicted adverse long-term outcome. In children and adolescents with JIA participation in school activities is mostly high after 8 years of disease. For the minority with low participation, special attention is warranted to promote their full potential of social interaction and improve long-term outcome.nb_NO
dc.language.isoengnb_NO
dc.publisherBioMed Centralnb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleParticipation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort studynb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber1-10nb_NO
dc.source.volume17:44nb_NO
dc.source.journalPediatric Rheumatologynb_NO
dc.identifier.doi10.1186/s12969-019-0341-6
dc.identifier.cristin1722231
dc.description.localcodeOpen Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.nb_NO
cristin.unitcode194,65,15,0
cristin.unitcode1920,1,0,0
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.unitnameBarne- og ungdomsklinikken
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal